Nano-X CEO buys 10,000 shares at $0.69
Rhea-AI Filing Summary
Nano-X Imaging Ltd. (NNOX) reports that Chief Executive Officer and director Erez Meltzer, through a wholly owned company, purchased 10,000 ordinary shares of the company on September 15, 2026 at $0.69 per share, increasing his indirectly held position to 65,443 shares. He also directly holds 60,584 ordinary shares and maintains stock options over 490,234 underlying shares at exercise prices between $2.21 and $23.84, with expirations from 2030 to 2034, some of which vest over time through April 16, 2028. No Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 10,000 shares
Net Buy
5 txns
Insider
Meltzer Erez
Role
Chief Executive Officer
Bought
10,000 shs ($7K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Ordinary Shares F1 | 10,000 | $0.69 | $7K |
| holding | Stock Option (right to buy ordinary shares) F2, F3 | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) F2, F4 | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) F2, F5 | -- | -- | -- |
| holding | Ordinary Shares F2 | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 65,443 shares (Indirect, By a wholly owned company);
Stock Option (right to buy ordinary shares) — 490,234 contracts (Direct);
Ordinary Shares — 60,584 shares (Direct)
Footnotes (5)
- F1. The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person.
- F2. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F3. The options reported in this row were granted to the Reporting Person by the Issuer on February 11, 2020 and are fully vested and exercisable as of the date of this report.
- F4. The options reported in this row were granted to the Reporting Person by the Issuer on January 2, 2020 and are fully vested and exercisable as of the date of this report.
- F5. The options reported in this row were granted to the Reporting Person by the Issuer on April 16, 2024, and vest and become exercisable in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested on the four-year anniversary of that grant date (April 16, 2028).
Key Figures
Shares purchased: 10,000 shares
Purchase price: $0.69 per share
Indirect holdings after transaction: 65,443 shares
+4 more
7 metrics
Shares purchased
10,000 shares
Ordinary shares bought on September 15, 2026 by a wholly owned company of the CEO
Purchase price
$0.69 per share
Price paid for the 10,000 ordinary shares purchased on September 15, 2026
Indirect holdings after transaction
65,443 shares
Ordinary shares held indirectly by a wholly owned company after the purchase
Direct ordinary share holdings
60,584 shares
Ordinary shares held directly by Erez Meltzer as of this Form 4
Options at $2.21 exercise price
40,234 underlying shares
Stock options expiring February 11, 2030, fully vested and exercisable
Options at $23.84 exercise price
300,000 underlying shares
Stock options expiring January 2, 2032, fully vested and exercisable
Options at $11.52 exercise price
150,000 underlying shares
Stock options expiring April 16, 2034, vesting through April 16, 2028
Key Terms
indirect ownership, fully vested and exercisable, exercise price, expiration date, +1 more
5 terms
indirect ownership financial
"reported as indirect ownership "By a wholly owned company""
fully vested and exercisable financial
"options reported were granted and are fully vested and exercisable"
exercise price financial
"Stock Option with an exercise price of $2.21 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"Stock Option expiring on February 11, 2030"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Rule 10b5-1 regulatory
"No Rule 10b5-1 trading plan is reported for this transaction"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did NNOX CEO Erez Meltzer report on this Form 4?
He purchased 10,000 ordinary shares of Nano-X Imaging Ltd. on September 15, 2026 at $0.69 per share in an open-market or private transaction through a wholly owned company.
What Nano-X (NNOX) stock options does the CEO have at a $2.21 exercise price?
Erez Meltzer holds stock options with a $2.21 exercise price over 40,234 underlying ordinary shares, expiring on February 11, 2030. These options were granted on February 11, 2020 and are fully vested and exercisable.
What higher-strike NNOX stock options are reported for the CEO?
He holds options over 300,000 underlying shares at an exercise price of $23.84, expiring January 2, 2032, and options over 150,000 underlying shares at $11.52, expiring April 16, 2034.
Are the Nano-X (NNOX) CEO’s stock options fully vested?
Options granted on January 2, 2020 and February 11, 2020 are fully vested and exercisable. Options granted on April 16, 2024 vest 25% after one year, then 6.25% quarterly over three years, becoming fully vested on April 16, 2028.
AI-generated analysis. How Rhea-AI works. Not financial advice.
